Inactive Instrument

Insiders Genmab Nasdaq Copenhagen

Equities

DK0010272202

Real-time Estimate Cboe Europe Other stock markets 14:18:16 18/06/2024 BST			5-day change	1st Jan Change
1,807 ^DKK	+48.48%		+4.14%	+14.24%

06-10	Transcript : Genmab A/S Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 09:20 AM
06-04	Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Genmab A/S Announces Executive Changes	03-13	CI
Danish Biotechnology Group Genmab Names New Chief Strategy Officer	28/03/23	MT
Genmab A/S Announces Appointment of Martine van Vugt to Chief Strategy Officer and Promotes to Executive Vice President Effective March 29, 2023	28/03/23	CI
Avantor Names Jonathan Peacock Chairman	13/05/22	MT
Genmab A/S Elects Elizabeth O’Farrell to the Board of Directors	29/03/22	CI
Genmab Appoints New Chief Legal Officer, Chief People Officer	01/03/22	MT
Genmab A/S Announces Appointments of Birgitte Stephensen to Chief Legal Officer and Chris Cozic to Chief People Officer	01/03/22	CI
Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines	22/02/21	CI
Genmab A/S Appoints Pernille Erenbjerg as Deputy Chairman	26/03/20	CI
Genmab A/S Announces the Election of Mr. Jonathan Peacock to its Board of Directors for a One-Year Period	26/03/20	CI
Genmab A/S Announces Anthony Mancini Will Join the Company as Executive Vice President and Chief Operating Officer, Effective March 23, 2020	10/03/20	CI
Genmab' Chairman of the Board of Directors, Mats Pettersson to Step Down from the Board At Annual General Meeting on March 26, 2020	21/02/20	CI
Genmab A/S Announces Executive Changes	30/10/19	CI
Genmab A/S Announces Management Changes	11/03/19	CI
Genmab A/S Appoints Judith Klimovsky as Executive Vice President and Chief Development Officer, Effective February 13, 2017	08/02/17	CI
Genmab A/S Nominates Rolf Hoffmann to its Board of Directors	03/08/16	CI
Genmab A/S Announces Board Appointments	26/03/15	CI
Genmab A/S Elects Mats Pettersson to the Board of Directors	17/04/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab: A good start to 2024; guidance unchanged

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 06:08 pm

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW